Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol

被引:220
|
作者
Stolk, Elly [1 ]
Ludwig, Kristina [1 ,2 ]
Rand, Kim [3 ,4 ]
van Hout, Ben [5 ]
Ramos-Goni, Juan Manuel [1 ]
机构
[1] EuroQol Res Fdn, Marten Meesweg 107, NL-3068 AV Rotterdam, Netherlands
[2] Bielefeld Univ, Hlth Econ & Hlth Care Management, Bielefeld, Germany
[3] Univ Oslo, Dept Hlth Management & Hlth Econ, Oslo, Norway
[4] Akershus Univ Hosp, Hlth Serv Res Ctr, Lorenskog, Norway
[5] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England
关键词
discrete choice experiment; EQ-5D-5L; health valuation; time trade-off; utilities; VALUE SET; HEALTH; UTILITY; MULTIATTRIBUTE; VALUES; INDEX;
D O I
10.1016/j.jval.2018.05.010
中图分类号
F [经济];
学科分类号
02 ;
摘要
A standardized 5-level EuroQol 5-dimensional questionnaire (EQ-5D-5L) valuation protocol was first used in national studies in the period 2012 to 2013. A set of problems encountered in this initial wave of valuation studies led to the subsequent refinement of the valuation protocol. To clarify lessons learned and how the protocol was updated when moving from version 1.0 to the current version 2.1 and 2.0, this article will (1) present the challenges faced in EQ-5D-5L valuation since 2012 and how these were resolved and (2) describe in depth a set of new challenges that have become central in currently ongoing research on how EQ-5D-5L health states should be valued and modeled. Copyright (c) 2019, ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:23 / 30
页数:8
相关论文
共 50 条
  • [21] The development of new research methods for the valuation of EQ-5D-5L
    Devlin, Nancy J.
    Krabbe, Paul F. M.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2013, 14 : S1 - S3
  • [22] Retraction Note to: The EQ-5D-5L Valuation Study in Egypt
    Sahar A. Al Shabasy
    Maggie M. Abbassi
    Aureliano Paolo Finch
    Darrin Baines
    Samar F. Farid
    PharmacoEconomics, 2021, 39 : 971 - 971
  • [23] CHOICE DEFINES QALYS: A US VALUATION OF THE EQ-5D-5L
    Craig, B. M.
    Rand, K.
    VALUE IN HEALTH, 2018, 21 : S12 - S12
  • [24] RETRACTED ARTICLE: The EQ-5D-5L Valuation Study in Egypt
    Sahar A. Al Shabasy
    Maggie M. Abbassi
    Aureliano Paolo Finch
    Darrin Baines
    Samar F. Farid
    PharmacoEconomics, 2021, 39 : 549 - 561
  • [25] Competing Views on the English EQ-5D-5L Valuation Set
    Norman, Richard
    Olsen, Jan Abel
    VALUE IN HEALTH, 2020, 23 (05) : 574 - 575
  • [26] Quality Control Process for EQ-5D-5L Valuation Studies
    Ramos-Goni, Juan M.
    Oppe, Mark
    Slaap, Bernhard
    Busschbach, Jan J. V.
    Stolk, Elly
    VALUE IN HEALTH, 2017, 20 (03) : 466 - 473
  • [27] The EQ-5D-5L international protocol and the Canadian experience
    Xie, Feng
    QUALITY OF LIFE RESEARCH, 2013, 22
  • [28] Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets
    van Hout, Ben
    Janssen, M. F.
    Feng, You-Shan
    Kohlmann, Thomas
    Busschbach, Jan
    Golicki, Dominik
    Lloyd, Andrew
    Scalone, Luciana
    Kind, Paul
    Pickard, A. Simon
    VALUE IN HEALTH, 2012, 15 (05) : 708 - 715
  • [29] Determinants of time trade-off valuations for EQ-5D-5L health states: data from the Canadian EQ-5D-5L valuation study
    Al Sayah, Fatima
    Bansback, Nick
    Bryan, Stirling
    Ohinmaa, Arto
    Poissant, Lise
    Pullenayegum, Eleanor
    Xie, Feng
    Johnson, Jeffrey A.
    QUALITY OF LIFE RESEARCH, 2016, 25 (07) : 1679 - 1685
  • [30] Determinants of time trade-off valuations for EQ-5D-5L health states: data from the Canadian EQ-5D-5L valuation study
    Fatima Al Sayah
    Nick Bansback
    Stirling Bryan
    Arto Ohinmaa
    Lise Poissant
    Eleanor Pullenayegum
    Feng Xie
    Jeffrey A. Johnson
    Quality of Life Research, 2016, 25 : 1679 - 1685